Debrisoft Resources

09 February 2026
An evaluation of Debrisoft® Duo was undertaken at Accelerate, a Community Interest Company (CIC), over a period of three months in 2025. This evaluation was undertaken independently by the clinical team, which included seven clinicians across three sites. Thirty patients participated in the project, presenting with a variety of aetiologies including venous leg ulceration, hyperkeratosis and non-diabetic foot ulceration. This resulted in 102 episodes of mechanical debridement across the cohort. Data was collected using e-Kare inSight®, pre- and post-debridement. This was enhanced by feedback from participants. Key findings included average time to debride which was two to four minutes, in >98% of the episodes clinicians identified visible changes within two minutes, the average reduction in devitalised tissue was 29, and clinicians reported the new Debrisoft Duo was more eͿective than the standard Debrisoft® debridement pad.
Topics:  Evaluation
03 December 2012

Wound debridement plays an essential role in preparing the wound to heal and can be achieved in several ways. Most wound debridement requires the skills of specialist practitioners which can be both time consuming and expensive. This observational study looks at a new mechanical debridement system with a monofilament fibre pad that can be used in any healthcare setting with minimal training. In twenty patients with wounds and/or skin that required debridement, the new system was found to be a fast and effective method of debridement causing minimal pain to the patients. This new approach to wound debridement could potentially have far reaching benefits to the patient, the nurse and the organisation.

Susan Johnson, RN, MA, ANP, NMP. Lead Nurse Wound Care, Doncaster Royal Infirmary,
Agnes Collarte, BSN, RN. Tissue Viability Nurse, Central London Community Healthcare NHS
Loty Lara, BSN, RN. Tissue Viability Nurse, Central London Community Healthcare NHS
Andreia Alberto, MSc. Tissue Viability Nurse, Central London Community Healthcare NHS

Article accepted for publication: July 2012

Topics:  Debrisoft